Table 1.
Characteristics considered for assessment of risk of bias adapted to Cochrane approach Study Quality Guide [28].
Fig 1.
Flowchart of the systematic review process.
Table 2.
Incidence of ESRD in populations with incident and prevalent diabetes–study characteristics.
Table 3.
Incidence of ESRD in populations with incident and prevalent diabetes–results.
Table 4.
Incidence of ESRD in populations with prevalent diabetes partly compared to non-diabetic populations–results.
Fig 2.
Age-sex-adjusted relative risks of ESRD due to all causes between diabetic and non-diabetic populations.
ESRD, end-stage renal disease. Confidence intervals (CI) were not shown as not all studies reported incidence rates of ESRD with the corresponding 95% CIs.
Fig 3.
Time trend of age-adjusted incidence rates of ESRD due to diabetic nephropathy.
ESRD, end-stage renal disease; IR, incidence rate. Confidence intervals (CI) were not shown as not all studies reported incidence rates of ESRD with the corresponding 95% CIs.